To highlight the role of immunohistochemistry to lung cancer classification on the basis of existing guidelines and future perspectives
The current state of molecular knowledge on lung cancer demands a histological classification which ...
Introduction The current WHO classification of lung cancer states that a diagnosis of SCLC can be re...
Introduction The current WHO classification of lung cancer states that a diagnosis of SCLC can be re...
Lung cancer remains the commonest global cause of death from cancer [1]. Notable advances in the dia...
Non-small cell lung cancer is possibly the solid tumor with more potential drugable molecular target...
Immunohistochemistry is a widely available technique that is less challenging and can provide clinic...
The identification of certain genomic alterations (EGFR, ALK, ROS1, BRAF) or immunological markers (...
The main purpose of this thesis was to evaluate selected biological factors that may help in typing,...
Since the 2015 WHO classification was introduced into clinical practice, immunohistochemistry (IHC) ...
The use of immunohistochemistry for the determination of pulmonary carcinoma biomarkers is a well-es...
Context.-A vast majority of neoplasms arising from lung or pleura are initially diagnosed based on t...
Objectives: To assess immunohistochemical (IHC) stains differentially expressed between different ty...
istopathologic classification of lung carcinoma is important, as a prognostic factor and in the eval...
Histopathological classification of lung cancer is of central importance in the diagnostic routine a...
Background : There are limitations of histomorphology in the appropriate categorization of lung car...
The current state of molecular knowledge on lung cancer demands a histological classification which ...
Introduction The current WHO classification of lung cancer states that a diagnosis of SCLC can be re...
Introduction The current WHO classification of lung cancer states that a diagnosis of SCLC can be re...
Lung cancer remains the commonest global cause of death from cancer [1]. Notable advances in the dia...
Non-small cell lung cancer is possibly the solid tumor with more potential drugable molecular target...
Immunohistochemistry is a widely available technique that is less challenging and can provide clinic...
The identification of certain genomic alterations (EGFR, ALK, ROS1, BRAF) or immunological markers (...
The main purpose of this thesis was to evaluate selected biological factors that may help in typing,...
Since the 2015 WHO classification was introduced into clinical practice, immunohistochemistry (IHC) ...
The use of immunohistochemistry for the determination of pulmonary carcinoma biomarkers is a well-es...
Context.-A vast majority of neoplasms arising from lung or pleura are initially diagnosed based on t...
Objectives: To assess immunohistochemical (IHC) stains differentially expressed between different ty...
istopathologic classification of lung carcinoma is important, as a prognostic factor and in the eval...
Histopathological classification of lung cancer is of central importance in the diagnostic routine a...
Background : There are limitations of histomorphology in the appropriate categorization of lung car...
The current state of molecular knowledge on lung cancer demands a histological classification which ...
Introduction The current WHO classification of lung cancer states that a diagnosis of SCLC can be re...
Introduction The current WHO classification of lung cancer states that a diagnosis of SCLC can be re...
DOI
Add to ORKG